4/A//SEC Filing
JAEGER STEPHEN O 4/A
Accession 0001181431-10-038100
CIK 0000722104other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 1:27 PM ET
Size
6.0 KB
Accession
0001181431-10-038100
Insider Transaction Report
Form 4/AAmended
JAEGER STEPHEN O
Director
Transactions
- Award
Common Stock, $.01 par value per share
2010-06-08−7,029→ 56,063 total
Footnotes (3)
- [F1]The right to receive these shares is pursuant to a restricted stock unit grant, 100% of which shall vest 30 days from the first anniversary of the Company's 2010 Annual Meeting of Stockholders. Mr. Jaeger has elected to defer receipt of such shares upon vesting until the earliest of his death, disability or retirement from the Board of Directors of the Company and a change of control of the Company.
- [F2]Due to administrative error, Mr. Jaeger was reported in a filing on June 10, 2010 to have acquired 7,029 shares of restricted stock on June 8, 2010.
- [F3]Mr. Jaeger received these restricted stock units as a grant forming part of his annual compensation as a director and Chairman of the Board of the company and for no consideration.. The restricted stock units had an aggregate fair market value of $79,990.32 based on the $11.38 per share closing price of the Company's common stock as quoted by the Nasdaq Global Market on the date of grant.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001243960
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 1:27 PM ET
- Size
- 6.0 KB